|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-4-13
|
|
pubmed:abstractText |
Although several candidate gene polymorphisms (SNPs) have been associated with increased risk of type 2 diabetes mellitus (T2DM), relatively few studies have assessed the ability of T2DM candidate genes to assess the risk of impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and T2DM beyond the information provided by clinical risk factors.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1365-2060
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
196-206
|
|
pubmed:meshHeading |
pubmed-meshheading:20384434-Adolescent,
pubmed-meshheading:20384434-Adult,
pubmed-meshheading:20384434-Aged,
pubmed-meshheading:20384434-Alleles,
pubmed-meshheading:20384434-Body Mass Index,
pubmed-meshheading:20384434-Diabetes Mellitus, Type 2,
pubmed-meshheading:20384434-Female,
pubmed-meshheading:20384434-Genetic Markers,
pubmed-meshheading:20384434-Genotype,
pubmed-meshheading:20384434-Glucose Metabolism Disorders,
pubmed-meshheading:20384434-Humans,
pubmed-meshheading:20384434-Male,
pubmed-meshheading:20384434-Middle Aged,
pubmed-meshheading:20384434-Phenotype,
pubmed-meshheading:20384434-Polymorphism, Single Nucleotide,
pubmed-meshheading:20384434-Predictive Value of Tests,
pubmed-meshheading:20384434-ROC Curve,
pubmed-meshheading:20384434-Risk Assessment,
pubmed-meshheading:20384434-Risk Factors,
pubmed-meshheading:20384434-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Combining genetic markers and clinical risk factors improves the risk assessment of impaired glucose metabolism.
|
|
pubmed:affiliation |
Department of Preventive Medicine, Laval University, 2300 rue de la Terrasse, Quebec, Canada.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
